The Omaha-003 clinical trial is for participants who have metastatic castration-resistant prostate cancer (mCRPC) and have failed to respond to drugs or surgery to block the testes from making hormones, and after treatment with other drugs for prostate cancer. The Omaha-004 clinical trial is for participants who have metastatic castration-resistant prostate cancer (mCRPC) and whose […]
What Are PARP Inhibitors? PARP inhibitors (often called PARPi) are cancer medicines you take as pills. PARP is a protein your cells use to fix small breaks in their DNA. PARP inhibitors block this repair process. When cancer cells can’t fix their DNA damage, they may stop growing or die. PARP inhibitors studied and used […]
Prostate cancer is often treatable. Many people do well with surgery, radiation, or hormone therapy. However, sometimes the cancer comes back. Sometimes it spreads to other parts of the body. When that happens, doctors and researchers look for new options. One option being studied is a T-cell engager therapy. It is a type of immunotherapy that […]
